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Frequent Aberrant Immunoglobulin Gene
Rearrangements in Pro-B Cells Revealed
by a bcl-xL Transgene
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et al., 1985; Cleary and Sklar, 1985; Korsmeyer, 1992;Christopher A. Pennell,* James J. Rivard,²
Yue-Sheng Li,³ Richard R. Hardy,³ Boise et al., 1993; Fang et al., 1994; Gonzalez-Garcia et
al., 1994; Reed, 1994; Cory, 1995). Expression of bcl-2Mark S. Schlissel,§ and Timothy W. Behrens*²
*Center for Immunology is developmentally regulated in both B and T lineages,
with high levels observed in early lymphoid progenitors²Department of Medicine
University of Minnesota Medical School and in mature cells (Reed et al., 1992; Li et al., 1993; Veis
et al., 1993a; Merino et al., 1994). Targeted disruption ofMinneapolis, Minnesota 55455
³Institute for Cancer Research bcl-2, however, has no obvious effects on lymphoid
development and results in the disappearance of theFox Chase Cancer Center
Philadelphia, Pennsylvania 19111 mature immune system by apoptosis (Nakayama et al.,
1993; Veis et al., 1993b). Stimulation of bcl-22/2 lympho-§Department of Medicine
Department of Molecular Biology and Genetics cytes by antigen specific T±B collaboration resulted in
their long-term survival (Nakayama et al., 1995), sug-Johns Hopkins University School of Medicine
Baltimore, Maryland 21205 gesting that Bcl-2 is required only for the maintenance of
naive mature lymphocytes and is dispensable following
activation. In contrast with bcl-22/2 animals, bcl-x2/2
mice die at embryonic day 13 with massive apoptosisSummary
of brain and fetal liver hematopoetic cells (Motoyama
et al., 1995). In the RAG2 blastocyst complementationDuring B lymphocyte development, pro-B cells that
system, bcl-x2/2 lymphocytes develop to maturity withfail to rearrange an immunoglobulin heavy (IgH) chain
low efficiency, the small pre-B population is markedlyallele productively are thought to undergo develop-
reduced, and the lifespan of immature lymphocytes ismental arrest and death, but because these cells are
diminished (Motoyama et al., 1995). Thus, Bcl-x appearsshort-lived in vivo they are not well characterized.
to have a critical role in regulating survival during earlyTransgenic mice expressing the apoptosis regulatory
lymphoid development.gene bcl-xL in the B lineage developed large ex-
In the present study, we have investigated the normalpansions of pro-B cells in bone marrow. V(D)J re-
expression of bcl-xL during B cell development and havearrangements in the expanded population were nearly
characterized the BM phenotype of transgenic mice ov-all nonproductive, and DJH rearrangements were
erexpressing bcl-xL in the B lineage. The highest levelsenriched for joints in DH reading frame 2 and for aber-
of Bcl-xL mRNA and protein are expressed in pro- andrant joints with extensive DH or JH deletions. Thus,
pre-B cells, in a pattern distinctly different from thatthe death of pro-B cells with failed immunoglobulin
of Bcl-2. Transgenic mice for bcl-xL in the B lineagerearrangements occurs by apoptosis, and bcl-xL can
developed a large expansion of the pro-B cell pool,deliver a strong survival signal at the pro-B stage. This
consisting of small long-lived cells. Sequencing re-analysis also demonstrates that immunoglobulin gene
vealed that the expanded population contains a highrearrangement is less precise than previously ap-
frequency of nonproductive V(D)J rearrangements andpreciated.
unusual DJH alleles with large nucleotide deletions.
These results support the hypothesis that Bcl-x has aIntroduction
unique role in regulating survival during early B cell de-
velopment.The early development of B lymphocytes in bone mar-
row (BM) is characterized by the ordered rearrangement
Results and Discussionof immunoglobulin genes (Tonegawa, 1983; Alt et al.,
1987). At the pro-B cell stage, cells first undergo DH-
Stage-Specific Expression of bcl-xL duringto-JH rearrangement on both heavy (H) chain alleles,
Normal B Cell Developmentfollowed by VH-to-DJH recombination. A productive re-
To investigate the normal expression of the Long iso-arrangement results in the expression of m protein,
form of bcl-x (bcl-xL) during B cell development, we firstwhich signals for H chain allelic exclusion and progres-
examined mRNA levels in sorted fractions of B lineagesion to the pre-B cell stage of development (Kitamura
cells (Figure 1A) (Hardy et al., 1991; Li et al., 1993). bcl-et al., 1991; Kitamura and Rajewsky, 1992; Schatz et al.,
xL mRNA was expressed at highest levels in fraction1992; Spanopoulou et al., 1994; Young et al., 1994),
D, which corresponds to the small pre-B cell stage ofwhile nonproductive rearrangements likely result in a
development. Half-maximal levels of bcl-xL expressiondevelopmental arrest and death of the cells (LoÈ ffert et
were detected in fractions B and C, which represental., 1994; Osmond et al., 1994). Because pro-B cells
early pro-B and late pro-B/early pre-B cells, respec-without a functional H chain are presumably short-lived
tively, and low levels were detected in the remainingin vivo, this population has not previously been carefully
studied. fractions A, E, and F. These results contrast sharply with
those of bcl-2, which was highly expressed in fractionsThe death repressor genes bcl-2 and bcl-x, which
block diverse apoptotic pathways in lymphocytes, are A and F only, and at low levels throughout the middle
stages of B cell development.candidates to regulate the cell death that occurs during
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Figure 1. Bcl-xL and Bcl-2 Expression during Normal B Cell Devel-
opment
(A) Relative expression levels of bcl-xL (circles) and bcl-2 (squares)
mRNA in B lineage fractions sorted from normal mouse BM. Fraction
A, pre±pro-B; fraction B, early pro-B; fraction C, late pro-B/early
pre-B; fraction D, late pre-B; fraction E, immature B; fraction F,
mature B. Cells in fractions A, B, and C express the CD43 (S7)
surface marker. Data represents the mean 6 SD of 3±5 independent
PCR amplifications per point and at least 2 independent cell sorts.
(B) Western blot of Bcl-xL and Bcl-2 protein in flow-sorted normal
mouse BM. Unfractionated (total) BM or BM B cell subpopulations
were sorted as described in Experimental Procedures. Cell equiva-
lents (106) were loaded in each lane except lane 2, which contains
10 mg cell lysate. WEHI 231: mouse immature sIgM1 B cell line,
expresses Bcl-2 butnot Bcl-xL (Fang et al., 1995). RAW 264.7: mouse
macrophage cell line stimulated for 10 hr with interferon-g and lipo-
polysaccharide, positive control for Bcl-xL (Transduction Labora-
tories). Molecular masses: Bcl-xL, 31, 32 kDa; Bcl-2, 26 kDa;
b-tubulin, 55 kDa. Relative expression levels of Bcl-xL normalized
to b-tubulin control as determined by densitometry: A±C, 3.7; D,
15.0; E and F, 1.0).
We then sorted B2201CD431 (Figure 1A, pro-B, frac-
tions A±C), B2201CD432immunoglobulin M2 (IgM2)
(pre-B, fraction D) and surface IgM1 cells (fractions E, F),
and performed Western blot analysis of protein lysates. Figure 2. Expansion of Long-Lived B2201 CD431 Pro-B Cells in bcl-
Figure 1B demonstrates that Bcl-xL protein expression xL Transgenic Bone Marrow
closely mirrors mRNA expression with significant ex- (A) The bcl-xL transgenic expression construct contains the IgH
pression in pro-B cells, 4-fold higher levels in pre-B chain intron enhancer (Em), the herpes virus thymidine kinase pro-
moter (tk P), and a human growth hormone 39 minigene (39 hGH).cells, and barely detectable levels in surface IgM1 cells
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Table 1. B Lineage Fractions in Bone Marrow of bcl-xL Transgenic and Control Mice
Fraction A Fraction B Fraction C Fraction D Fraction E Fraction F
Mice Percentage
bcl-xL Transgenic 1.5 9.9 1.3 5.7 2.1 4.2
(1.3, 1.7) (6.4, 13.5) (1.5, 1.0) (5.0, 6.4) (1.3, 3.0) (2.6, 5.7)
Control 1.4 1.7 0.3 7.0 3.0 5.8
(1.3, 1.5) (2.0, 1.3) (0.2, 0.3) (7.9, 6.1) (2.5, 3.4) (4.1, 7.4)
BM cell suspensions of bcl-xL transgenic or control mice were analyzed by four-color flow cytometry, and the percentage of cells in Fractions
A±F determined. The average of two experiments is presented (individual experiments are in parentheses). B 1 C 5 11.2% for bcl-xL transgenic
and 2.0% for controls (average of 2 mice each). Other fractions were not significantly different.
of the BM. These results were quite different than the type littermatics. BM cell counts were 86 6 11 3 106
cells in transgenics versus 52 6 6 3 106 cells in wildpattern observed with Bcl-2 protein, which was ex-
type (mean 6 SEM; n 5 8; p < 0.002 by Student's pairedpressed at significant levels early in development, as
t test). Strikingly, the transgenic BM exhibited an ex-previously reported (Merino et al., 1994). Thus, bcl-xL
panded population of cells that stained positively forand bcl-2 mRNA and protein are expressed in nearly
the pan-B cell marker B220 and the pro-B cell markerreciprocal patterns during normal mouse B cell devel-
CD43/leukosialin (Hardy et al., 1991), but lacked expres-opment.
sion of surface IgM (B220lo, CD431, sIgM2) (Figure 2B).
In Table 1, the results of four-color flow cytometryGeneration of Bcl-xL Transgenic Mice
analysis of B cell subsets in the transgenic and wild-To explore the influence of Bcl-x in developing B cells,
type control mice are presented. We observed a 4- totransgenic mice expressing bcl-xL in the B cell lineage
5-fold expansion in the size of fractions B and C pro-Bwere generated. A plasmid vector containing the m H
populations, while the pre-B (fraction D) and the surfacechain intron enhancer and a herpes virus thymidine ki-
IgM1 pools (fractions E and F) were similar to wild-typenase promoter (Figure 2A) was used to direct expression
littermates (compare with Figure 2B). The size of fractionof the mouse bcl-xL cDNA (Fang et al., 1995). Four inde-
C in the control mice (C57BL/6 3 FVB intercrosses)pendent transgenic founders on the FVB/N genetic
is lower than previously observed for BALB/c animalsbackground (Taketo et al.,1991) demonstrated an identi-
(Hardy et al., 1991; Li et al., 1993), owing to lower levelscal bone marrow phenotype, and the (FVB 3 C57BL/
of BP-1 antigen expression in the C57BL/6 strain6)F1 or (FVB 3 C57BL/6)F2 progeny (4±10 weeks of age)
(R. R. H., unpublished data). Since BP-1 expression dis-of two high copy founders were studied in detail.
tinguishes fraction B (BP-1 neg) from fraction C (BP-1Expression of transgenic bcl-xL mRNA was restricted
pos), the results shown in Table 1 may underestimateto spleen, BM, and lymph nodes (data not shown), tis-
the number of cells in fraction C and overestimate thosesues that also express endogenous bcl-x mRNA (Fang
in fraction B. To rule out the possibility that the expan-et al., 1994; Gonzalez-Garcia et al., 1994) and that are
sion of pro-B cells was due to unexpectedly high levelsnormally populated by B lymphocytes. B lineage±
of transgenic expression at the pro-B cell stage, reverserestricted expression was confirmed by immunoblot of
transcriptase polymerase chain reaction (RT±PCR) wastissue lysates (data not shown) and by functional analy-
used to confirm that the bcl-xL transgene was expressedsis of the peripheral immune system (W. F. et al., unpub-
at similar levels throughout B cell development
lished data).
(B2201CD431 cells, B2201CD432 cells, and surface
IgM1 splenocytes; data not shown).Bcl-xL Transgenic Mice Exhibit a Large Primary in vitro culture of BM demonstrated that theExpansion of the Pro-B Cell Compartment
bcl-xL transgenic B cell progenitors have a significantTotal cellularity of BM was increased by approximately
survival advantage compared with wild type (Figure 2C).
65% in the bcl-xL transgenes compared with their wild- Greater than 95% of the surviving cells at day 10 of
culture are resting in the G0/G1 stage of the cell cycle,
and these cells have remained viable in culture for 4±6
The mouse bcl-xL cDNA was engineered with a FLAG epitope tag weeks in the absence of exogenous growth factors (data
(IBI/Kodak) (hatched box). N, NotI; E, EcoRI; A, ApaI; pBS, pBlues- not shown).
cript II KS(1) (Stratagene).
The immunoglobulin gene rearrangementstatus of the(B) Two-color flow cytometric analysis of freshly isolated bone mar-
pro-B (B2201CD431) and more mature B lineage cellsrow from wild-type or transgenic littermates stained with anti-B220
(B2201CD432) was then examined in flow-sorted popu-and either anti-CD43 or anti-IgM MAbs. Forward-by-side light scat-
lations of both transgenic and wild-type littermates.ter plots of whole BM are shown at the top, with the lymphoid gate
circled (R1). The lower four panels illustrate only the lymphoid cells, Analysis of D±JH and V±DJH rearrangements in genomic
with numbers referring to percentage of total ungated BM cells. The DNA showed no large differences between bcl-xL
data is representative of more than 20 pairs of mice analyzed. transgenic and wild-type mice (Figure 3). k re-
(C) Representative primary whole BM culture at 10 days. Shown are
arrangements (V±Jk) and broken DNA ends 59 of Jk wereanti-B220 and anti-CD43 staining of the lymphoid cells (R1 gate)
enriched in the CD432 populations, and broken DNAthat survive the 10 day culture period. Photomicrographs of the
ends 59 of DH were more abundant in the CD431 cellscultures (bottom) demonstrate aggregates of transgenic lymphoid
cells on the primary stroma. Original magnification, 2003. of both transgenic and wild-type mice. Locus-specific
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were also normal in the CD431 and CD432 cells of
the transgenes (data not shown). Therefore, the ex-
panded population of B2201CD431 pro-B cells in bcl-xL
transgenic mice initiate and properly regulate genomic
DNA rearrangements at both the H and L chain immuno-
globulin loci, and are indistinguishable from wild-type
littermates in expression of several B cell±specific
mRNA transcripts.
Increased Frequency of Aberrant DJH Joints
in Bcl-xL Transgenic Pro-B Cells
The sequences of DJH joints amplified from genomic
DNA of wild-type and transgenic B2201, CD431 pro-B
cells are presented in Figures 4A, 4B (data summarized
in Table 2). In transgenic pro-B cells, there were twice
as many joints in the ªforbiddenº DH reading frame 2
(RF2) (Reth and Alt, 1984; Gu et al., 1991; Ehlich et al.,
1994; LoÈ ffert et al., 1994) as were found in wild type (10
of 24 versus 5 of 24). DH RF2, however, was found to
be counterselected normally in CD432 D±JH joints of
bothwild-type and transgenic mice (Table 2). The normal
underrepresentation of RF2 usage in mature B cells is
thought to be due to the loss of pro-B cells expressing
the Dm protein, encoded by DJH joints when the DH seg-
ment is in the second reading frame with respect to the
JH coding region (Reth and Alt, 1984; Gu et al., 1991;
Ehlich et al., 1994; LoÈ ffert et al., 1994). The interaction
of Dm with surrogate L chain may signal for H chain allelic
exclusion and death at the pro-B cell stage (Tsubata et
al., 1991; LoÈ ffert et al., 1994).
Of interest, the transgenic pro-B cell population wasFigure 3. The Expanded Population of Bcl-xL Transgenic Pro-B
also enriched for aberrant D±JH rearrangements (9 of 26Cells Undergoes Immunoglobulin Gene Rearrangements
joints) that deleted either the entire JH coding regionGenomic DNA (104 cell equivalents/lane) prepared from flow-sorted
B2201, CD431 (431, lanes 1 and 3) or B2201, CD432 (432, lanes 2 or the upstream nonamer/heptamer signal sequences
and 4) BM cells from wild-type and transgenic mice, as well as required for VH-to-DJH recombination (Figure 4B; Table
control mouse spleen DNA (lane 6) were amplified by PCR under 2) (Tonegawa, 1983). These aberrantly rearranged D±JH
limiting conditions and blotted with specific DNA probes. The three
joints would not be capable of producing functionalbands in the D±JH blot correspond to rearrangements DJH1, DJH2,
V(D)J joints, and were found rarely in wild-type pro-Band the smallest product, DJH3. Similarly, the three bands shown
cells (2 of 24 joints).for V±DJH correspond to V(D)JH1, V(D)JH2, and V(D)JH3. The PCR
product of the VJk1 recombination is shown. Analysis of broken
DNA ends (BE) 59 of DH and 59 of JH, normal intermediates in recombi- V(D)J Rearrangements in Transgenic Pro-B
nation, are shown in the lower two panels. Equivalence of analyzed Cells Are Predominantly Nonproductive
DNA samples was confirmed by amplification of class I MHC (data
The majority of V(D)J rearrangements in the more maturenot shown).
B lineage cells (B2201CD432) of both wild-type and
transgenic animals were productive in-frame joints (Ta-
ble 2). Unexpectedly, while 17 of 22 V(D)J joints frombroken DNA ends indicate active V(D)J recombination
and are likely a normal intermediate in recombination wild-type pro-B cells were productive (Figure 4C), there
was only a single productive rearrangement of the 31(Schlissel et al., 1993). Expression of sterile k transcripts,
and mRNA for the surrogate light (L) chain l5 and RAG1 V(D)J joints sequenced from the expanded population
Figure 4. Nucleotide Sequences of Pro-B Cell DJH and V(D)J Joints
(A, B) DJH sequences. Genomic DNA from flow-sorted wild-type (A) and bcl-xL transgenic (B) pro-B cell fractions was amplified with an
upstream DH primer conserved between the DSP and DFL16 DH families, and a reverse primer complementary to genomic DNA downstream
of JH3. The DJH3 joints were then cloned and sequenced. Shown are the heptamer signals of the DH segments (in lowercase), DH segments,
N or P nucleotide additions, and the 59 JH3 segments. The reading frame of each DH segment is indicated by 1, 2, or 3. Unusual joints that
delete a portion of the upstream DH heptamer/nonamer or the entire JH3 coding region are indicated with an X. In the aberrant joints, the DH
family and reading frame were assigned by upstream DH leader sequence. All noncoding DNA is in lowercase characters.
(C, D) V(D)J sequences. Genomic DNA from wild-type (C) and bcl-xL transgenic (D) BM fractions was amplified using an upstream degenerate
VH558 family primer and the JH3 primer described above. Shown are the 39 VH558 segment beginning with the conserved cysteine 92 (TGT),
DH segment, N or P nucleotides and the 59 JH3 segment for each joint. The reading frame of the DH segment, and nonproductive (NP) or
productive (P) joints are indicated. DH segments were assigned only if 5 or more unambiquous germline nucleotides were identified. In-frame
stop codons are underlined. Ns refer to sequencing ambiguities, and bold type indicates nongermline-encoded nucleotides that likely reflect
amplification errors. Allelic variants of DFL16.1 and DSP2.x, likely of FVB/N origin, are marked with an asterisk.
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Table 2. Increased Frequency of Unusual DJH and Nonproductive V(D)J Sequences in bcl-xL Transgenic Pro-B Cells
Wild-type littermates bcl-xL Transgenic
Sequences Joints B2201 CD431 B2201 CD432 B2201 CD431 B2201 CD432
DJH sequences RF1 10/24 9/17 6/24 6/16
RF2 5/24 1/17 10/24 1/16
RF3 9/24 7/17 8/24 9/16
Heptamer/nonamer or JH3 deletions 2/24 1/17 9/26a 0/16
Potentially productive DJH3 joints 10/24 (42%) 8/17 (47%) 5/26 (19%) 7/16 (44%)
Productive V(D)J joints 17/22 (77%) 11/12 (92%) 1/31 (3%)b 13/15 (87%)
V(D)J sequences DH in RF1 9/16 7/9 7/24 12/13
DH in RF2 1/16 0/9 3/24 0/13
DH in RF3 6/16 2/9 14/24 1/13
Summary of the sequence analysis of DH-JH3 and V(D)J (VH558-to-DJH3) joints from the indicated wild-type and bcl-xL transgenic BM B cell
fractions (from Figure 4 and CD43[2] fraction sequences not shown). The number of DJH3 joints in DH reading frame (RF) 1, 2, or 3 are noted.
The number of joints that deleted either heptamer or nonamer signal sequences upstream of DH or the JH3 coding region (two of the CD431
transgenic joints) are indicated. The two joints in the transgenic CD431 group that deleted JH3 (Figure 4B) were not included in the RF analysis.
Potentially productive DJH joints exclude the joints in RF2 and those with in-frame stop codons or deletions. Productive V(D)J joints are in
frame and lack stop codons. The number of V(D)J joints with the DH segment in RF1, RF2, or RF3 is noted. DQ52 joints have a stop codon
upstream of the nonamer in RF2 and were excluded from the V(D)J RF analysis. Joints in which less than 5 germline-encoded DH nucleotides
could be unambiguously assigned were also excluded.
a x2 5 3.61, p 5 0.058 compared with wild-type B2201 CD431.
b x2 5 28.24, p , .001 compared with wild-type B2201 CD431.
of transgenic pro-B cells (Figure 4D; Table 2). The non- Taken together, these findings support a model in
which Bcl-xL expression is up-regulated at the earlyproductive joints were either in the third DH segment
reading frame, which contains stop codons in most DH pro-B stage (fraction B) and serves to support cell sur-
vival during the rearrangement of H chain alleles. Cellssegments (Kaartinen and Maleka, 1985), or had N region
nucleotide additions that resulted in out-of-frame joints with a functional H chain rearrangement then further up-
regulate Bcl-xL expression, and become competent toor provided in-frame stop codons. These data suggest
that many of the cells in the expanded transgenic pro-B undergo L chain rearrangements and subsequent selec-
tion events in the bone marrow. At the mature stagepopulation have nonfunctional V(D)J rearrangements of
both H chain alleles, leading to a block in developmental (IgM1, IgD1), Bcl-x levels are low and the up-regulation
of Bcl-2 protein is required for the survival of naive recir-progression.
These results indicate that Bcl-xL has a unique role in culating cells. In this model, pro-B cells that fail to re-
arrange a H chain allele productively die in the boneregulating survival during early B lymphocyte develop-
ment. The expression patterns of bcl-xL and bcl-2 were marrow by apoptosis. We speculate that the normal
apoptotic death of pro-B cells lacking a functional re-found to be distinctly different, with bcl-2 mRNA ex-
pressed at high levels at the pre±pro-B and mature B arrangement may be due to the eventual down-regula-
tion of Bcl-x expression in the absence of H chain signal-stages, while Bcl-xL mRNA and protein expression was
up-regulated in pro-B cells and peaked at the pre-B ing. Constitutive expression of Bcl-xL by the transgene
interrupts this censoring process, and results in the ob-stage (see Figure 1). Bcl-xL has also recently been shown
to be expressed highly in double-negative thymocytes served pro-B expansions.
Our results indicating that 77% of the V(D)J joints(Ma et al., 1995), indicating a possible conserved func-
tion of Bcl-x in regulating survival during the early devel- in wild-type pro-B cells were functionally rearranged
contrasts with data reported recently by Ehlich and col-opment of B and T lymphocytes.
Surprisingly, the bcl-xL transgenic mice developed leagues (Ehlich et al., 1994). This group examined immu-
noglobulin rearrangements in single cells from flow-large expansions of B2201 CD431 pro-B cellscontaining
mostly aberrant immunoglobulin gene rearrangements. sorted B cell progenitors, and found a lower percentage
of productive V(D)J alleles in fractions B and C (overall,bcl-2 B cell transgenic mice may also have a small
expansion of early B lineage cells (Merino et al., 1994), 7 of 32 alleles, or 22%). Technical aspects of the single-
cell analysis reported by Ehlich resulted in an underrep-but it appears to be much less prominent than the dis-
tinct population observed in the bcl-xL transgenic mice. resentation of cells with a single V(D)J rearrangement,
which might have excluded cells in fractions B or CThese data also complement the reported phenotypes
of knockout mice for either bcl-2 or bcl-x. bcl-22/2 mice with a single productive V(D)J allele. Thus, the differing
techniques (a single cell analysis of individual sortedhave no apparent abnormalities in lymphoid develop-
ment, but mature naive lymphocytes are subject to rapid Hardy fraction cells by Ehlich et al. versus the popula-
tion-based approach we used) and the relatively smallapoptosis (Nakayama et al., 1993, 1995; Veis et al.,
1993b). In contrast, bcl-x2/2 B lymphocytes progress to number of alleles examined to date may account for the
reported differences. Further work will be required tothe mature stage with very low efficiency (Motoyama et
al, 1995; Ma et al., 1995), and there is a marked decrease address this point definitively.
Transgenic pro-B cells were enriched for DJH jointsin the small pre-B cell population (Motoyama et al.,
1995). rearranged in RF2; however, counterselection of RF2
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BM Culturesoccurred normally in the transgenic CD432 cells (Table
BM from transgenic mice was harvested from all extremity long2). This implies that the death of Dm-expressing pro-B
bones as described in Coligan et al. (1991). BM suspensions (5 3cells occurs via apoptosis, and further that Dm protein
106 cells, 5 ml in 10 cm2 wells) were cultured for 10 days in 50%
expression results in a failure to progress through devel- RPMI, 50% EHAA media (Biofluids) supplemented with 10% fetal
opment even in the presence of a strong anti-apoptotic calf serum (Hyclone), 2 mM L-glutamine, and 50 mM 2-ME. Before
flow cytometry of these cultures, cells were harvested from thesignal. Transgenic pro-B cells were also found to be
primary stroma layer by gentle pipetting. Photomicrographs wereenriched for unusual DJH rearrangements that delete
taken with a Nikon inverted microscope using Hoffman optics.critical elements required for productive V(D)J recombi-
nation. A significant source of junctional diversity in re-
Flow Cytometry Analysiscombination is the variable trimming of coding ends
Two-color flow cytometry of transgenic BM was performed on aprior to their ligation (Alt and Baltimore, 1982). This exo-
FACScan (Becton-Dickinson) with Lysis II software using Cy-
nuclease-mediated truncation at coding joints generally Chrome±conjugated anti-B220 monoclonalantibodies (MAbs) (RA3±
ranges from 0±8 bases, with rare DJH joints deleting up 6B2), fluorescein isothiocyanate (FITC)-conjugated anti-CD43/leu-
to 15 nt (Feeney et al., 1994; Lewis, 1994). Thus, the kosialin MAbs (S7), FITC-conjugated anti-IgM MAbs (R6-60.2), and
isotype-matched control MAbs (Pharmingen). Single-cell suspen-aberrant DJH joints with large deletions that remove non-
sions of BM were collected from lympholyte interfaces, washedamer/heptamer signal sequences or the JH coding re-
with phosphate-buffered saline three times, incubated with staininggions likely reflect the normal heterogeneity of DH±JH antibodies for 30 min on ice in 2% fetal calf serum/phosphate-
recombinants that, similar to Dm-expressing cells, are buffered saline, and washed again before analysis. Sorting of
normally purged from the BM by apoptosis. The high transgenic BM fractions for genomic DNA and RNA was performed
frequency of these unusual DJH deletions in the at the University of Minnesota core facility on a FACStar Plus (Bec-
ton-Dickinson) with gates that excluded all B220intermediate and B220hitransgenics suggests that the fidelity of immunoglobulin
cells from the B2201CD431 fractions. Four-color analysis of BM Bgene rearrangement is lower than previously appreci-
cell subpopulations intransgenic and wild-type mice was performedated (discussed by Lewis, 1994).
as described (Hardy et al., 1991; Li et al., 1993).
The expanded population of bcl-xL transgenic pro-B
cells highlights the essential role for apoptotic cell death
mRNA Expressionin deleting early B lineage cells with failed or otherwise
The method for investigating gene expression in sorted fractions of
nonproductive immunoglobulin gene rearrangements. B lineage cells has been described previously (Li et al., 1993). In
The paucity of out-of-frame V(D)J joints in the more brief, BM was obtained from 2- to 4-month-old female BALB/cAnN
mature CD432 transgenic population indicates that ex- mice bred in the Institute for Cancer Research animal facility. A
single-cell suspension of BM (femur and tibia) was prepared bypression of Bcl-xL alone is not sufficient for lineage pro-
flushing bones with staining medium, and cells were then stainedgression, and that thebcl-xL transgene does not interfere
with appropriate reagents (B220/CD43/HSA/BP-1 for fractions A±C,with selection on the basis of a functional H chain re-
B220/CD43/IgM/IgD for fractions D±F). Flow cytometry analysis and
arrangement at the pro-B to pre-B transition. Finally, sorting was carried out using a dual laser/dye laser flow cytometer
these data suggest that m H chain protein must deliver (FACStar Plus, Becton-Dickenson) equipped with filters for four-
positive signals in addition to anti-apoptotic signals for color immunofluorescence. Samples wereheld on ice during sorting,
and reanalysis of sorted fractions consistently showed purities inpro-B cells to advance to the pre-B cell stage of devel-
excess of 95%. Cells (105) of each selected population were depos-opment.
ited directly into microcentrifuge tubes containing guanidinium thio-
cyanate lysis buffer (Chirgwin et al., 1979). RNA was isolated byExperimental Procedures
ultracentrifugation over 5.7 M CsCl and ethanol precipitation of the
pelleted material. RT±PCR was carried out for 18/22 cycles (b-actin)Transgenic Construct and Mice
or 22/26 cycles (bcl-2, bcl-xL) as described previously (Li et al.,The transgenic expression vector pJT1 was constucted by first in-
1993). After agarose electrophoresis, DNA was transferred to nylonserting the IgH chain intron enhancer (Em) (Lenardo et al., 1987) into
membranes and hybridized with 32P-labeled riboprobes made fromthe XbaI and EcoRI sites of pBluescript II KS(1) (Stratagene). The
the PCRproducts. Each PCR fragment was designed to span exons,human growth hormone 39 minigene (39 hGH) was then excised from
to allow discrimination of amplified cDNA from that of contaminatingp1017 (Chaffin et al., 1990) with BamHI and EcoRI, linkered with
DNA. Signal intensity was quantitated by two-dimensional scintilla-XhoI, and cloned into the XhoI site of the pBS polylinker. Finally,
tion counting. PCR primers used were the following: b-actin: 59the herpes virus TK promoter (2109 to 163) was amplified with Pfu
CCTAAGGCCAACCGTGAAAAG, 59 TCTTCATGGTGCTAGGAGCCA;polymerase (Stratagene) from the pT109luc plasmid (American Type
bcl-2: 59 TCGCTACCGTCGTGACTTC, 59 AAACAGAGGTCGCATGCulture Collection) with primers that added a SrfI site and flanking
CTG; bcl-xL: 59 TGCGTGGAAAGCGTAGACAAGG, 59 AGTGGATGGTHindIII sites, and this fragment was cloned into the HindIII site of
CAGTGTCTGGTCAC.the pBS polylinker. An XhoI-linkered mouse bcl-xL cDNA engineered
with a FLAG epitope tag (IBI/Kodak) (Fang et al., 1995) was then
cloned into the SalI site of the pJT1 expression plasmid. The 3.8 kb Western Blot of Sorted B Cell Precursors
A three-color sort was performed at the University of Minnesotatransgenic cassette was excised with NotI and ApaI, gel purified,
dialyzed, and microinjected into FVB/N fertilized eggs (Taketo et core facility on a FACStar Plus (Becton-Dickinson). In brief, 80 3
106 BM cells from two C57BL/6 mice were stained with Cy-Chrome±al., 1991) using standard procedures (Hogan et al., 1994) at the
University of Minnesota Transgenic Facility. Mice were maintained anti-B220, phycoerythrin±anti-CD43, and FITC±anti-IgM. B2201-
CD431IgM2 cells (fractions A±C) were collected for the duration ofin conventional facilities, and (FVB 3 C57BL/6)F1 or F2 animals
between the ages of 4±10 weeks were studied. Transgene copy the sort, and B2201IgM1 cells (fractions E, F) or B2201CD432IgM2
cells (fraction D) were collected individually. Postsort analysisnumber was estimated by densitometry of the 3.2 kb transgenic
EcoRI Southern blot restriction fragment, and ranged from 7±15 showed greater than 99% pure populations. Cell lysates (1 3 106
cell equivalents/lane) were immunoblotted using enhanced chemilu-copies in the four founders studied. Genotypes were determined
by Southern blot or by PCR with the following primers: 59 GACTA- minescence (Amersham) as previously described (Fang et al., 1995).
The blot was sequentially probed with a 1/500 dilution of each ofCAAGGACGACGATGAC, and 59 CCTGAGTGGTTCGGGGAGTTG,
corresponding to the FLAG epitope and a sequence from the 39 the following antibodies: Bcl-x MAb (Transduction Laboratories),
Bcl-2 MAb (3F11, Pharmingen), and b-tubulin MAb (Sigma).hGH minigene, respectively.
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Genomic DNA Amplifications D.L., and Behrens, T.W. (1995). Bcl-xL rescues WEHI 231 B lympho-
cytes from oxidant-mediated death following diverse apoptoticGenomic DNA was prepared from flow-sorted cell populations em-
bedded in agarose as described (Schlissel et al., 1993). D±JH, V±DJH, stimuli. J. Immunol. 155, 66±75.
V±Jk amplifications and the broken DNA end assay were performed Feeney, A.J., Victor, K.D., Vu, K., Nadel, B., and Chukwuocha, R.U.
as previously detailed (Schlissel et al., 1991, 1993). DH±JH3 joints (1994). Influence of the V(D)J recombination mechanism on the for-
were amplified from genomic DNA using Pfu polymerase (Stra- mation of the primary T and B cell repertoires. Sem. Immunol. 6,
tagene) with an upstream DH primer conserved between the DSP 155±163.
and DFL16 families and a reverse primer complementary to genomic
Gonzalez-Garcia, M., Perez-Ballestero, R., Ding, L., Duan, L., Boise,DNA downstream of JH3 (Schlissel et al., 1991). The DJH3 bands L.H., Thompson, C.B., and Nunez, G. (1994). bcl-xL is the major bcl-were cloned into PCR±Script (Stratagene) and sequenced using an
x mRNA form expressed during murine development and its productinternal JH3 primer (59 AACATGCATTTAGAATGG). V(D)J joints were localizes to mitochondria. Development 120, 3033±3042.amplified with a VH558 family upstream primer and the JH3 down-
Gu, H., Kitamura, D., and Rajewsky, K. (1991). B cell developmentstream primer (Schlissel et al., 1991). The VH558±DJH3 bands were
regulated by gene rearrangement: arrest of maturation by mem-cloned and sequenced as described above. The choice of JH3 joints
brane-bound Dmu protein and selection of DH element readingshould not introduce a bias into the analysis (see Gu et al., 1991).
frames. Cell 65, 47±54.Sequences of the CD43(2) clones are available upon request.
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